However, the optimal methodology for assessing Ki-67 levels in breast cancer that fulfils the criteria of perfect inter-rater and inter-laboratory reproducibility has not yet been identified4,6,8,10,13,19,23,27. This evidence concerns the gene MKI67 and breast cancer.